-
公开(公告)号:US07943767B2
公开(公告)日:2011-05-17
申请号:US12622545
申请日:2009-11-20
申请人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A. R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Quinghua Weng , James David Beard
发明人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A. R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Quinghua Weng , James David Beard
IPC分类号: C07D487/04 , C07D403/04 , C07D401/14 , A61K31/53 , A61P35/00
CPC分类号: C07D487/04 , A61K31/5025 , C07D253/07 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14
摘要: Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐是mTOR的抑制剂,可用于治疗癌症。
-
公开(公告)号:US07700594B2
公开(公告)日:2010-04-20
申请号:US11599663
申请日:2006-11-15
申请人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A. R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
发明人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A. R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
IPC分类号: C07D487/04 , C07D401/14 , C07D403/04 , A61K31/53 , A61K31/4523 , A61K35/00
CPC分类号: C07D487/04 , A61K31/5025 , C07D253/07 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14
摘要: Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐是mTOR的抑制剂,可用于治疗癌症。
-
公开(公告)号:US08796455B2
公开(公告)日:2014-08-05
申请号:US13767947
申请日:2013-02-15
申请人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A. R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
发明人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A. R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
IPC分类号: C07D487/04 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14 , A61K31/5025 , A61P19/02 , A61P35/00
CPC分类号: C07D487/04 , A61K31/5025 , C07D253/07 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14
摘要: Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐是mTOR的抑制剂,可用于治疗癌症。
-
公开(公告)号:US20110218183A1
公开(公告)日:2011-09-08
申请号:US13106954
申请日:2011-05-13
申请人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A.R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kem W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
发明人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A.R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kem W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
IPC分类号: A61K31/4985 , C07D487/04 , A61K31/53 , C07D519/00 , A61K31/5377 , A61P35/00
CPC分类号: C07D487/04 , A61K31/5025 , C07D253/07 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14
摘要: Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐是mTOR的抑制剂,可用于治疗癌症。
-
公开(公告)号:US20090163468A1
公开(公告)日:2009-06-25
申请号:US12326536
申请日:2008-12-02
申请人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joesph Mulvihill , Paula A.R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
发明人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joesph Mulvihill , Paula A.R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
IPC分类号: A61K31/397 , C07D487/02 , A61K31/4985 , A61K31/5377 , C07F5/02 , A61P19/02 , A61P37/00 , A61P35/00 , C07D253/06 , C07D413/14 , A61K31/53
CPC分类号: C07D487/04 , A61K31/5025 , C07D253/07 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14
摘要: Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐是mTOR的抑制剂,可用于治疗癌症。
-
公开(公告)号:US20130165651A1
公开(公告)日:2013-06-27
申请号:US13767947
申请日:2013-02-15
申请人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A.R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
发明人: Xin Chen , Heather Coate , Andrew Philip Crew , Han-Qing Dong , Ayako Honda , Mark Joseph Mulvihill , Paula A.R. Tavares , Jing Wang , Douglas S. Werner , Kristen Michelle Mulvihill , Kam W. Siu , Bijoy Panicker , Apoorba Bharadwaj , Lee D. Arnold , Meizhong Jin , Brian Volk , Qinghua Weng , James David Beard
IPC分类号: C07D487/04
CPC分类号: C07D487/04 , A61K31/5025 , C07D253/07 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/14
摘要: Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
摘要翻译: 由式(I)表示的化合物或其药学上可接受的盐是mTOR的抑制剂,可用于治疗癌症。
-
公开(公告)号:US20110015197A1
公开(公告)日:2011-01-20
申请号:US12922928
申请日:2009-03-18
IPC分类号: A61K31/53 , C07D487/04 , A61P35/00
CPC分类号: C07D487/04
摘要: Salt forms of mTOR inhibitors of the Formula (I): and methods of preparation, formulation, and use in treating disease.
摘要翻译: 式(I)的mTOR抑制剂的盐形式:及其制备,配制和用于治疗疾病的方法。
-
公开(公告)号:US20120041202A1
公开(公告)日:2012-02-16
申请号:US13265363
申请日:2010-04-19
IPC分类号: C07D487/04 , C07D241/16 , C07D401/10
CPC分类号: C07D487/04 , C07D241/16
摘要: A process for preparing a compound of formula (I) or a salt thereof: (I) wherein R1 is H or optionally substituted aryl or heteroaryl; comprising reacting 2,3-dichloropyrazine with a suitable diaryl imine followed by hydrolysis.
摘要翻译: 制备式(I)化合物或其盐的方法:其中R 1为H或任选取代的芳基或杂芳基的(I) 包括使2,3-二氯吡嗪与合适的二芳基亚胺反应,然后水解。
-
公开(公告)号:US20130123501A1
公开(公告)日:2013-05-16
申请号:US13812629
申请日:2011-07-29
申请人: Arlindo L. Castelhano , Gary A. Cutting , Andrew J. Locke , Kristen Michelle Mulvihill , Robert Norrie , Andrew J. O'brien , Stuart R. Park , Josef A. Rechka , Andrew MIchael Stevens , Christopher I. Thomas
发明人: Arlindo L. Castelhano , Gary A. Cutting , Andrew J. Locke , Kristen Michelle Mulvihill , Robert Norrie , Andrew J. O'brien , Stuart R. Park , Josef A. Rechka , Andrew MIchael Stevens , Christopher I. Thomas
IPC分类号: C07D487/04
CPC分类号: C07D487/04
摘要: Process for preparing the tyrosine kinase inhibitor OSI-906 comprises coupling Compound (2) with Compound (6) under specified conditions.
摘要翻译: 制备酪氨酸激酶抑制剂OSI-906的方法包括在特定条件下将化合物(2)与化合物(6)偶联。
-
公开(公告)号:US08557814B2
公开(公告)日:2013-10-15
申请号:US12922928
申请日:2009-03-18
IPC分类号: A61K31/53 , C07D487/04
CPC分类号: C07D487/04
摘要: Salt forms of mTOR inhibitors of the Formula (I): and methods of preparation, formulation, and use in treating disease.
摘要翻译: 式(I)的mTOR抑制剂的盐形式:及其制备,配制和用于治疗疾病的方法。
-
-
-
-
-
-
-
-
-